Država: Novi Zeland
Jezik: engleski
Izvor: Medsafe (Medicines Safety Authority)
Cefaclor monohydrate 52.45 mg/mL equivalent to Cefaclor 50 mg/mL (with 2.5% overage)
Novartis New Zealand Ltd
Cefaclor monohydrate 52.45 mg/mL (=Cefaclor 50 mg/mL; with 2.5% overage)
250 mg/5mL
Granules for oral suspension
Active: Cefaclor monohydrate 52.45 mg/mL equivalent to Cefaclor 50 mg/mL (with 2.5% overage) Excipient: Dimeticone Iron oxide yellow Maize starch Methylcellulose Sodium laurilsulfate Strawberry flavour 052312 AP0551 Sucrose Xanthan gum
Bottle, glass, 60 mL
Prescription
Prescription
ACS Dobfar SpA
Package - Contents - Shelf Life: Bottle, glass, - 60 mL - 24 months from date of manufacture stored at or below 25°C 14 days reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Bottle, glass, - 100 mL - 24 months from date of manufacture stored at or below 25°C 14 days reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)
2000-04-19
NEW ZEALAND DATASHEET CEFACLOR SANDOZ _CEFACLOR MONOHYDRATE PH EUR, POWDER FILLED CAPSULE, 250 MG AND 500 MG, _ _GRANULES FOR ORAL SUSPENSION 125 MG/5 ML AND 250 MG/5 ML (AS CEFACLOR) _ PRESENTATION _CEFACLOR SANDOZ CAPSULES _ 250 MG Capsule, powder filled, Size 2, reddish brown opaque cap and body. Each capsule contains cefaclor monohydrate equivalent to cefaclor 250 mg. 500 MG Capsule, powder filled, Size 0, reddish brown opaque cap and body. Each capsule contains cefaclor monohydrate equivalent to cefaclor 500 mg. _CEFACLOR SANDOZ GRANULES FOR ORAL SUSPENSION _ 125 MG/5 ML Suspension, oral, granules for, light yellow to orange yellow coloured. Reconstituted suspension contains in 5 ml, cefaclor monohydrate equivalent to cefaclor 125 mg. 250 MG/5 ML Suspension, oral, granules for, light yellow to orange yellow coloured. Reconstituted suspension contains in 5 ml, cefaclor monohydrate equivalent to cefaclor 250 mg. USES _ACTIONS _ PHARMACOTHERAPEUTIC GROUP J01DC04 – Second generation cephalosporins, cefaclor. MECHANISM OF ACTION Beta-lactam antibiotic. PHARMACODYNAMIC EFFECTS Inhibition of bacterial cell wall synthesis. ANTIBIOTIC CLASS Cefaclor monohydrate is a semi-synthetic cephalosporin for oral administration. ANTIBIOTIC NATURE AND MODE OF ACTION _In vitro _tests demonstrate that the bactericidal action of cephalosporins results from inhibition of cell- wall synthesis. SUSCEPTIBILITY DATA While _in vitro _studies have demonstrated the susceptibility of most strains of the following organisms to cefaclor, clinical efficacy for infections other than those included in the Indications section is unknown. Aerobes, Gram-positive: Staphylococci, including coagulase-positive, coagulase-negative, and penicillinase-producing strains; _Streptococcus pyogenes_ (Group A beta-haemolytic streptococci); _Streptococcus pneumoniae_;_ Corynebacterium_ spp. Aerobes, Gram-negative: _Moraxella (Branhamella) catarrhalis_; _Haemophilus influenzae_, including beta-lactamase-producing ampicillin-resistant strains; _Escherichia coli Pročitajte cijeli dokument